DN
Denali
DNLI·NASDAQS San Francisco CAFounded 2015600 employees
Mid CapbiotechPublicNeurology
Platform: TV BBB
Market Cap
$4B
All Drugs
3
Clinical Trials
7
Failed / Terminated
2
FDA Approved
0
Stock Price & Catalysts (DNLI)
Loading DNLI stock data...
Drug Pipeline (3 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Cevimavacamten | DNL-9415 | NDA/BLA | 2 | Menin | FLRSV | ||
| DNL-9555 | DNL-9555 | Phase 1/2 | 1 | KIF18A | EoEFabry | ||
| Fixafutibatinib | DNL-164 | Phase 3 | 4 | PRMT5 | CTCLHS |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (3)